secwatch.observer — SEC 8-K summary
======================================

Issuer:     Benitec Biopharma Inc. (BNTC)
CIK:        0001808898
Form:       8-K
Filed at:   2025-03-28T23:59:59+00:00
Accession:  0001193125-25-067232
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Benitec Biopharma closes ~$30.5M equity offering; issues 2.043M shares and pre-funded warrants
--------------------------------------------------------------------------------

- Gross proceeds ~$30.5M from underwritten offering of 1.143M shares + 300K pre-funded warrants at $13.00/$12.999 per share.
- Direct offering to Averill Master Fund and Averill Madison Master Fund of 900K shares at $13.00 per share.
- Post-closing: 25,546,288 common shares outstanding; warrants for 5,876,866 common shares and 15,270,807 pre-funded warrants.
- Pre-funded warrants have exercise price of $0.0001 per share.
- All securities sold in concurrent offerings at same price of $13.00 per share.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1808898/000119312525067232/0001193125-25-067232-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1808898/000119312525067232/d831106d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-067232

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer